HPV Vaccine Researcher Drops A Bombshell

Dr. Diane Harper, lead researcher in the development of two human papilloma virus vaccines, Gardasil and Cervarix, said the controversial drugs will do little to reduce cervical cancer rates and, even though they’re being recommended for girls as young as nine, there have been no efficacy trials in children under the age of 15. Dr. Harper, director of the Gynecologic Cancer Prevention Research Group at the University of Missouri, made these remarks during an address at the 4th International Public Conference on Vaccination which took place in Reston, Virginia on Oct. 2-4. Although her talk was intended to promote the vaccine, participants said they came away convinced the vaccine should not be received.
Read article in Alliance for Human Research Protection

The cervical cancer vaccine, Gardasil, has been linked to many cases of serious adverse reactions, including several deaths.

Cervical cancer drug Gardasil linked to deaths

Extract from Telegraph article:

"Fears have been raised over the safety of a cervical cancer vaccine which health officials plan to give all 12-year-old girls, after it was revealed that the drug has been linked to several deaths.

Three young women are reported to have died days after the drug Gardasil was administered, while the jab is also suspected of triggering "adverse reactions" in 1,700 patients. The figures were uncovered by campaigners who made a freedom of information request in the US, where the vaccine was approved for use a year ago.

Tom Fitton, the president of Judicial Watch, which extracted the data, said: "Reports on the vaccine read like a catalogue of horrors."

The women – aged 12, 19 and 22 – suffered heart attacks or blood clots after being injected with Gardasil, which protects against the sexually transmitted human papilloma virus which causes most cases of cervical cancer. Hundreds of others reported suffering what could be adverse reactions, including paralysis, seizures and miscarriages.

The news comes just days after the announcement that the drug would be added to the childhood immunisation programme."